首页> RSC medicinal chemistry> Ligand-centred phenotype-driven development of potent kinase inhibitors against oesophageal cancer.

Ligand-centred phenotype-driven development of potent kinase inhibitors against oesophageal cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Cecilia C,Ayala-Aguilera

第一单位： Edinburgh Cancer Research, Institute of Genetics & Cancer, University of Edinburgh Crewe Road South Edinburgh EH4 2XR UK asier.ub@ed.ac.uk.;Cancer Research UK Scotland Centre UK.

作者： Cecilia C,Ayala-Aguilera ^[1] ; Yang,Ge ^[1] ; Álvaro,Lorente-Macías ^[1] ; Benjamin N,Jones ^[1] ; Catherine,Adam ^[1] ; Neil O,Carragher ^[1] ; Asier,Unciti-Broceta ^[1]

作者单位： Edinburgh Cancer Research, Institute of Genetics & Cancer, University of Edinburgh Crewe Road South Edinburgh EH4 2XR UK asier.ub@ed.ac.uk.;Cancer Research UK Scotland Centre UK. ^[1]

DOI 10.1039/d4md00579a

PMID 39493221

发布时间 2025-01-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

RSC medicinal chemistry

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

检索历史清除

Ligand-centred phenotype-driven development of potent kinase inhibitors against oesophageal cancer.

RSC medicinal chemistry

相似文献

同项目论文

RSC medicinal chemistry

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Ligand-centred phenotype-driven development of potent kinase inhibitors against oesophageal cancer.

RSC medicinal chemistry

相似文献

同项目论文

RSC medicinal chemistry

相关期刊

检索历史清除